Owen A. Ross

June 1, 2023

Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration

Abstract Supplementary Information: The online version contains supplementary material available at 10.1186/s40478-023-01584-z. Article type: Case Report Keywords: Progressive supranuclear palsy,…

December 7, 2020

MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features

Abstract The microtubule-associated protein tau (MAPT) H1 haplotype is the strongest genetic risk factor for corticobasal degeneration (CBD). However, the…

September 17, 2020

Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures

Abstract Electronic supplementary material: The online version of this article (10.1186/s40478-020-01035-z) contains supplementary material, which is available to authorized users.…

January 9, 2018

Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies

Abstract Background: Converging evidence suggests that immune-mediated dysfunction plays an important role in the pathogenesis of frontotemporal dementia (FTD). Although…

June 16, 2015

Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy

Abstract Corticobasal degeneration (CBD) is a neurodegenerative disorder affecting movement and cognition, definitively diagnosed only at autopsy. Here, we conduct…